tyrosine and ponatinib

tyrosine has been researched along with ponatinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aslan, JE; Druker, BJ; Gruber, A; Healy, LD; Loren, CP; McCarty, OJ; Nowak, MS; Rigg, RA	1

Other Studies

1 other study(ies) available for tyrosine and ponatinib

Article	Year
The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear. Thrombosis research, 2015, Volume: 135, Issue:1 Topics: Amino Acid Motifs; Apoptosis; Blood Platelets; Collagen; Endothelial Cells; Fibrinogen; Fusion Proteins, bcr-abl; Humans; Imidazoles; Immunoreceptor Tyrosine-Based Activation Motif; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; P-Selectin; Phosphatidylserines; Phosphorylation; Platelet Activation; Platelet Aggregation; Pyridazines; Shear Strength; Signal Transduction; Tyrosine	2015

Article

Year

The BCR-ABL inhibitor ponatinib inhibits platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling, platelet activation and aggregate formation under shear.

Thrombosis research, 2015, Volume: 135, Issue:1

Topics: Amino Acid Motifs; Apoptosis; Blood Platelets; Collagen; Endothelial Cells; Fibrinogen; Fusion Proteins, bcr-abl; Humans; Imidazoles; Immunoreceptor Tyrosine-Based Activation Motif; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; P-Selectin; Phosphatidylserines; Phosphorylation; Platelet Activation; Platelet Aggregation; Pyridazines; Shear Strength; Signal Transduction; Tyrosine

2015